Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Aadi Bioscience Inc

AADI
Current price
2.17 USD +0.05 USD (+2.36%)
Last closed 2.17 USD
ISIN US00032Q1040
Sector Healthcare
Industry Biotechnology
Exchange NASDAQ
Capitalization 52 375 724 USD
Yield for 12 month -54.51 %
1Y
3Y
5Y
10Y
15Y
AADI
21.11.2021 - 28.11.2021

Aadi Bioscience, Inc., a biopharmaceutical company, engages in developing and commercializing precision therapies for genetically defined cancers with alterations in mTOR pathway genes. Its lead drug product candidate comprises FYARRO, a form of sirolimus protein-bound particles for injectable suspension for the treatment in adult patients with advanced unresectable or metastatic malignant PEComa. The company is also involved in evaluating FYARRO in cancers, including indications targeting specific genomic alterations that activate the mTOR pathway. Aadi Bioscience, Inc. was incorporated in 2007 and is headquartered in Pacific Palisades, California. Address: 17383 Sunset Boulevard, Pacific Palisades, CA, United States, 90272

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

1.88 USD

P/E ratio

Dividend Yield

Current Year

+24 354 000 USD

Last Year

+15 216 000 USD

Current Quarter

+7 212 000 USD

Last Quarter

+6 179 000 USD

Current Year

+21 545 000 USD

Last Year

+13 881 000 USD

Current Quarter

+7 212 000 USD

Last Quarter

+5 401 000 USD

Key Figures AADI

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -70 472 000 USD
Operating Margin TTM -252.21 %
PE Ratio
Return On Assets TTM -34.93 %
PEG Ratio
Return On Equity TTM -62.26 %
Wall Street Target Price 1.88 USD
Revenue TTM 23 817 000 USD
Book Value 4.28 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY -0.4 %
Dividend Yield
Gross Profit TTM -18 781 000 USD
Earnings per share -2.28 USD
Diluted Eps TTM -2.28 USD
Most Recent Quarter III 2024
Quarterly Earnings Growth YOY
Profit Margin -274.77 %

Dividend Analytics AADI

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History AADI

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor 1:15
Payout Ratio
Last Split Date 27.08.2021
Dividend Date

Stock Valuation AADI

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue 3.4826
Price Sales TTM 2.1991
Enterprise Value EBITDA -0.6156
Price Book MRQ 0.7587

Financials AADI

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators AADI

For 52 weeks

1.21 USD 5.7 USD
50 Day MA 1.95 USD
Shares Short Prior Month 352 158
200 Day MA 1.83 USD
Short Ratio 2.24
Shares Short 283 524
Short Percent 1.7 %